Last week, we launched our European FemTech Report having been immersed in the landscape for the past 9 months, analysing data from 540 FemTech companies from pre-seed to IPO! Here we share an overview of the report.
The FemTech sector has grown rapidly in the last few years, with global Venture Capital investment surpassing $2 billion for the first time in 2021. The sector is expected to be valued at over $60 billion by 2027, and most of this growth is accounted for in North America. The European FemTech sector is still in its infancy and is expected to grow to $35 billion by 2032.
There is a lot of attention on the FemTech market with top consulting firms conducting in-depth market research of the space. However, we’re still yet to see a comprehensive Europe-centred database or a thorough report addressing this region. Therefore, Sie Ventures has created an expansive European FemTech market map including key findings, shaped by data collected from over 540 active FemTech companies at various stages from pre-seed up to IPO.
While the US remains the largest global FemTech market, there are indicators showing that Europe is catching up. Through our market analysis, we have identified the leading regions in Europe, which
include the UK (31.8%), France (18.3%), Germany (12%), Sweden (7.9%) and Switzerland (5.5%)
We have also analysed the gender diversity across our database and discovered that over 70% of companies were founded by at least one female co-founder. Despite this proportion, raising capital still remains imbalanced and on average, a female-founded FemTech startup raised just $4.6M, compared to $9.2 million by those with all-male teams.
The rise in discussions and policies in Europe concerning women’s health is fuelling innovation in the FemTech industry. New policy recognition of women’s health concerns is driving changes in the regulatory environment. We have listed some of the biggest regulatory changes in the European
market. Among many other trends that drive the future innovations in the FemTech market, we have taken a deeper look at the changes at the workplace to attract and retain top female talent.
Women’s participation in the workforce has shifted dramatically in the past decades, driving the recognition of their needs in the workplace. With a growing number of female executives driving workplace inclusivity, benefits like fertility support can help improve performance and employee retention.
We at Sie Ventures remain committed to backing women’s health solutions as well as businesses led by women. We continue our efforts to build a more inclusive tech ecosystem in the UK and Europe and drive more capital to women led businesses through Sie Catalyst programs and Sie Syndicate.
A special mention to the founders and investors who contributed to the report: Felicia Von Reden (Co-Founder & CEO, Ovom Care), Jenny Saft (Co-Founder & CEO, Apryl), Tess Cosad (Founder & CEO, Béa Fertility), Gail Armstrong (Lavender Ventures), Chantal Cox (Octopus Ventures) & Peter Crane (Lunar Ventures).
You can download the full report here. If you have any questions or would like to connect with the Sie Team, drop us an email on hello@sie.ventures!
